Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Celularity (CELU) Return on Sales (2020 - 2025)

Celularity (CELU) has disclosed Return on Sales for 6 consecutive years, with 5.94% as the latest value for Q4 2025.

  • For Q4 2025, Return on Sales rose 1339.0% year-over-year to 5.94%; the TTM value through Dec 2025 reached 3.45%, down 188.0%, while the annual FY2025 figure was 3.45%, 239.0% down from the prior year.
  • Return on Sales hit 5.94% in Q4 2025 for Celularity, down from 4.37% in the prior quarter.
  • Across five years, Return on Sales topped out at 12.67% in Q2 2022 and bottomed at 30.64% in Q1 2021.
  • Average Return on Sales over 5 years is 6.69%, with a median of 3.0% recorded in 2024.
  • Year-over-year, Return on Sales soared 3285bps in 2022 and then tumbled -2899bps in 2023.
  • Celularity's Return on Sales stood at 0.83% in 2021, then surged by 811bps to 5.92% in 2022, then tumbled by -87bps to 0.79% in 2023, then tumbled by -2551bps to 19.32% in 2024, then skyrocketed by 69bps to 5.94% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 5.94%, 4.37%, and 4.28% for Q4 2025, Q3 2025, and Q2 2025 respectively.